AbbVie Inc.ABBV

Where ABBV's Net Debt / EBITDA sits inside its own 10-year distribution, with the yearly high, low and average.

$256.34-3.87 (-1.49%)Previous close
NYSEHealthcareDividend King

ABBV Net Debt / EBITDA: current value, 10-year range and year-by-year history

Net Debt / EBITDA History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
ABBV Net Debt / EBITDA historyABBV Net Debt / EBITDA from Sep 2023 to Jun 2026: low 2.5, high 4.93, latest 3.03.2.33.013.714.425.13Sep 23Mar 24Sep 24Jun 25Dec 25Jun 26med 3.5

ABBV Net Debt / EBITDA by year

Yearly range of ABBV’s net debt / ebitda from 2016 to 2026. Over the full period it ranged from 2.0 to 6.4, averaging 3.5.

ABBV Net Debt / EBITDA — yearly low, average, high and year-end values
YearLowAverageHighYear-end
20263.03.43.83.0
20253.64.44.93.6
20243.03.54.24.2
20232.42.62.82.8
20222.32.52.72.3
20212.84.05.12.8
20202.05.06.46.4
20192.23.84.62.2
20182.53.14.04.0
20172.62.83.02.7
20163.13.13.13.1

Get notified when ABBV Net Debt / EBITDA crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

How many years of operating earnings it would take to pay off the company's net debt. The most common leverage ratio — higher means more financial risk and less flexibility.

Formula(Total Debt − Cash) / EBITDA
Full guide
How to read this chart

Watch the trend more than the level. Declining ratio = deleveraging, growing financial flexibility. Rising ratio = increasing leverage, which constrains dividends, buybacks, and future investment.

Key caveats
  • Sector context is essential: 3× is aggressive for a consumer brand but normal for a regulated utility. Always compare to sector peers.
  • Large acquisitions spike the ratio temporarily — check whether the integration plan credibly drives paydown.
Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.